ComplianceOnline

Dimebon Failed in Clinical Trial - Hopes for Alzheimer’s Drug Are Torn Apart

  • Date: March 09, 2010
  • Source: admin
Webinar All Access Pass Subscription Abstract:

For the patients of Alzheimer’s, Dimebon was perhaps the brightest ray of hope but that hope also got dashed when the drug failed in the last stage of the first clinical trial. Its failure not only demoralized its hopeful patients but also blown Medivation and Pfizer – the two companies which were dealing with the medicine.

Bookmark and Share

Compliance Trainings

Compliance Measures for Case Managers
By - Toni Cesta
On Demand Access Anytime
Understanding HIPAA Risk Mitigation
By - Jay Hodes
On Demand Access Anytime

Compliance Standards

Best Sellers
You Recently Viewed
    Loading